The Vita Coco Company (COCO)
NASDAQConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-09-04
$55.13+0.09%
Close 2026-09-04 · 1-day change
NASDAQConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-09-04
QuarterlyIQ Insights · COCO
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $55 the market pays 30× p/e — above the 17× p/e peer median but in line with its own 50× history. That premium reflects a durable franchise our peer-anchored $69 fair value understates; treat the 'expensive vs peers' read with medium confidence. Analysts target $68–$90. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $81.50 | — | — | Analyst | high |
| dcf fcfe | 12M | $124.13 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $128.73 | — | — | Hist. CAGR | high |
| graham number | 12M | $16.54 | — | — | TTM | high |
| Peer EV/EBITDA |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$68.00 – $90.00 (median $81.50) · 4 analysts · as of 2026-07-28
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 81% over what the business is worth with no growth; closing that gap needs roughly 3.0 years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $1.28/sh owner earnings.
Looks more expensive than peers.
Cheaper than its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| 12M |
| $23.17 |
| 11.7 |
| 1.59 |
| TTM |
| high |
| Peer P/FCF | 12M | $32.65 | 15.9 | 2.05 | TTM | high |
| Peer P/E | 12M | $33.72 | 15.8 | 2.13 | ntm analyst | high |
| Peer P/S | 12M | $9.94 | 0.9 | 11.64 | TTM | high |
| PEG | 12M | $61.99 | 33.7 | 1.84 | TTM | high |
| residual income | 12M | $12.34 | — | — | TTM | high |
| Own P/E history | 12M | $92.64 | 50.4 | 1.84 | TTM | high |
| triangulated | 12M | $33.71 | 16.8 | 2.00 | Triangulated | high |
| Peer P/FCF | 3Y | $49.66 | 15.9 | 3.12 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $36.88 | 15.8 | 2.33 | Analyst | medium |
| Peer P/S | 3Y | $14.27 | 0.9 | 16.72 | guidance | medium |
| PEG | 3Y | $78.63 | 33.7 | 2.33 | Analyst | medium |
| Own P/E history | 3Y | $117.51 | 50.4 | 2.33 | Analyst | medium |
| Peer P/FCF | 5Y | $65.67 | 15.9 | 4.13 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $39.15 | 15.8 | 2.48 | Analyst | high |
| Peer P/S | 5Y | $15.16 | 0.9 | 17.76 | guidance | high |
| PEG | 5Y | $83.49 | 33.7 | 2.48 | Analyst | high |
| Own P/E history | 5Y | $124.77 | 50.4 | 2.48 | Analyst | high |